Laboratory Safety

Laboratory safety in a clinical genetics lab encompasses biological, chemical, physical, and waste-stream hazards. The dominant frameworks are CDC/NIH biosafety levels for biological agents, the OSHA bloodborne pathogen standard for human-source specimens, and the OSHA laboratory standard (chemical hygiene plan) for hazardous chemicals. Routine clinical specimens are handled at BSL-2 with universal precautions; higher containment is reserved for specific high-risk pathogens.

• Biosafety levels (BSL):
  • BSL-1: agents not known to cause disease in healthy adults (e.g., non-pathogenic E. coli lab strains). Standard microbiological practices, open-bench work, no specific containment.
  • BSL-2: agents posing moderate hazard via percutaneous, ingestion, or mucous-membrane exposure. All clinical specimens of human origin (blood, body fluids, tissue, cultured patient cells) are handled at BSL-2 under universal precautions. Requires biosafety cabinet (Class II BSC) for aerosol-generating procedures, autoclave on-site, restricted access, and PPE.
  • BSL-3: agents transmitted by inhalation that can cause serious or lethal disease (e.g., M. tuberculosis, SARS-CoV-2 culture, certain endemic mycoses). Directional airflow, sealed penetrations, respiratory protection, and double-door entry.
  • BSL-4: high-consequence agents with no available treatment (Ebola, Marburg, Lassa). Positive-pressure suits or Class III BSC, dedicated facility.
  • Unknown isolates from a patient with an undefined infection are handled at minimum BSL-2, often escalating to BSL-3 practices until identified.
• OSHA bloodborne pathogen standard (29 CFR 1910.1030):
  • Mandates an exposure control plan, universal/standard precautions (treat all human blood and OPIM as infectious), engineering controls (sharps containers, BSCs), work practice controls, PPE provided at no cost to the employee, hepatitis B vaccination offered, post-exposure evaluation and follow-up, and annual training.
  • Universal precautions: every patient specimen is treated as infectious regardless of known status.
• PPE basics: lab coat (closed front, full sleeves), gloves (changed between patients/procedures, doffed before leaving the lab), eye protection or face shield for splash-risk procedures, closed-toe shoes, and respiratory protection (N95 or PAPR) when the SOP requires it.
• Chemical hygiene plan (OSHA Lab Standard, 29 CFR 1910.1450): written plan addressing hazardous chemicals, including SOPs, exposure controls, ventilation/fume hoods, designated areas for particularly hazardous substances (e.g., ethidium bromide, formamide, phenol-chloroform), and emergency procedures.
• Safety Data Sheets (SDS, formerly MSDS): required for every hazardous chemical, accessible to all employees during their shift, containing 16 standardized sections (identification, hazards, composition, first aid, fire, accidental release, handling, exposure controls/PPE, physical/chemical properties, stability, toxicology, ecological, disposal, transport, regulatory, other). The transition from MSDS to SDS reflects OSHA alignment with the GHS hazard communication standard.
• Sharps and waste streams:
  • Sharps (needles, scalpels, broken glass, capillary tubes): rigid, puncture-resistant, labeled containers, never recapped, never overfilled (3/4 full max).
  • Red bag (regulated medical waste): any item soaked or saturated with blood/OPIM, microbiological cultures, pathological waste.
  • Chemical waste: segregated by compatibility (acid, base, halogenated organic, non-halogenated organic), labeled with full chemical name and accumulation start date.
  • General trash: only non-contaminated, non-hazardous items.
• Spill response: small biological spills are covered with absorbent, disinfected with freshly prepared 1:10 bleach (10-minute contact) or an EPA-registered disinfectant; large or aerosol-generating spills require area evacuation and notification of the safety officer. Chemical spills follow SDS-specified neutralization or absorption.
• Other hazards: liquid nitrogen (asphyxiation, cryogenic burns), UV transilluminators (eye/skin), centrifuges (rotor balance, sealed cups), and ergonomics (repetitive pipetting injury).

• A blood sample from a patient with unknown infection status is handled at BSL-2 with universal precautions; HIV or hepatitis B status is irrelevant to the precautions because all specimens are treated as infectious.
• Cultured patient lymphocytes for karyotype are still BSL-2 (human-origin cells).
• A needlestick triggers immediate wound care, source-patient and exposed-employee testing per the exposure control plan, and consideration of post-exposure prophylaxis - all paid for by the employer under the bloodborne pathogen standard.
• Pregnant lab staff or those planning pregnancy should review chemical and radiation exposures with the safety officer; some reagents (formamide, EtBr) and isotopes warrant additional precautions or task reassignment.